Antares Pharma Inc. (AIS) Key Ratios

Profile for Antares Pharma Inc.  (AIS) 
$ 2.59   -0.09 (-3.36%) Volume: 1.26 m 4:00 PM EST Feb 10, 2012
After Hours:  $ 2.59 0.00 (0.00%) Volume: 4.54 k 5:15 PM EST Feb 10, 2012
Income Statements
Revenue (LTM) ($): 14.31 m
Revenue per Share (LTM) ($): 0.14
Revenue per Employee (LTM) ($): 681,572.50
Revenue Growth 3 Yr: 34.73%
Revenue Growth 5 Yr: 26.49%
 
Dividends & Splits
Annual Dividend Rate ($): N/A
Annual Dividend Yield: N/A
Dividend Growth 3 Yr: N/A
Dividend Growth 5 Yr: N/A
Ex-Dividend Date: N/A
Payment Type: N/A
Financial Strength (LTM)
Quick Ratio: 4.20
Current Ratio: 4.40
Long Term Debt to Total Capital: N/A
Total Debt to Equity: N/A
Interest Coverage: N/A
Leverage Ratio: 1.20
 
Profitability (LTM)
Gross Margin: 62.50%
EBIT Margin: -38.60%
EBITDA Margin: -37.20%
Pre-Tax Profit Margin: N/A
Profit Margin (Cont. Op): -38.70%
Profit Margin (Total Op): -38.70%
Management Effectiveness LTM 5 Yr Avg
Return on Equity N/A N/A
Return on Capital -87.60% -87.60%
Return on Assets -47.70% -47.70%
 
Assets
Asset Turnover: 0.50
Inventory Turnover: 16.80
Receivable Turnover: 10.20
Valuation Measures
P/E Ratio: N/A
P/E High - Last 5 Years: N/A
P/E Avg. High - Last 5 Years: N/A
P/E Low - Last 5 Years: N/A
P/E Avg. Low - Last 5 Years: N/A
 
Price to Sales: 19.38
Price to Book: 8.68
Price to Tangible Book: 9.28
Price to Cash Flow: -50.00
Price to Free Cash: -48.40